Founded in 2001 in Stockholm, MedCap AB is a Swedish publicly listed investment company focused on acquiring and developing profitable, market-leading niche businesses in the life science industry. Listed on Nasdaq Stockholm’s Mid Cap segment, MedCap operates as a long-term owner through three business areas: Assistive Tech, MedTech, and Specialty Pharma. Headquartered in Stockholm, the group generated net sales of SEK 1.807 billion in 2024.
Updated 2026-03-19